Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Sense Media launch MediSens: a highly-anticipated European medical imaging conference

Built by medical practitioners and the world’s foremost digital imaging experts, this conference addresses the need for a more integrated approach to developing medical imaging systems for clinical use.

11 Oct 2016

Study highlights burden, poor prognosis of head and neck cancers linked to tobacco/alcohol

A nationwide study of head and neck cancers in France has revealed that the true burden of the disease is underestimated by at least one-third, and that head and neck cancers carry a very high risk of secondary primary cancers, according to two presentations at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Survey finds seven out of ten cancer patients receive palliative care consultation at ESMO Designated Centres

Seven out of ten patients with advanced cancer receive a palliative care consultation at ESMO Designated Centres of Integrated Oncology and Palliative Care, according to survey results reported today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Fulvestrant significantly increases progression-free survival in women with hormone-receptor-positive advanced breast cancer, particularly those with less aggressive lower-volume disease, researchers reported at the ESMO 2016 Congress in Copenhagen

8 Oct 2016

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves progression-free survival in postmenopausal women with hormone receptor-positive advanced breast cancer, researchers reported today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Study of pan-FGFR inhibitor uses mRNA in tumours to identify responders

The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metastatic solid tumours were reported today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for the first time at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine.

8 Oct 2016

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immunotherapy has shown promising results in first and second line treatment of metastatic bladder cancer in two phase II trials presented at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Ipilimumab as adjuvant therapy significantly improves overall survival in patients with high risk stage III melanoma, according to the EORTC 18071 phase III trial results presented for the first time today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

First comprehensive center opened in Tri-State area to mark new era in care of DMD patients

Nearly 1,000 boys in the New York Tri-State area have been diagnosed with Duchenne Muscular Dystrophy (DMD) and, until now, had to travel out of the state for comprehensive care.

7 Oct 2016

Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen.

7 Oct 2016

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.

7 Oct 2016

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in Copenhagen.

7 Oct 2016

Study finds neoadjuvant immunotherapy safe, viable for early lung cancer patients before surgery

Neoadjuvant immunotherapy with the PD-1 inhibitor nivolumab is safe and feasible prior to surgery for early lung cancer, researchers reported at the ESMO 2016 Congress in Copenhagen.

7 Oct 2016

Pitt researchers show how repair protein finds structural errors in DNA

Researchers at the University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute have demonstrated how Rad4, a protein involved in DNA repair, scans the DNA in a unique pattern of movement called "constrained motion" to efficiently find structural faults in DNA.

7 Oct 2016

Studies look at alternative ways to overcome barriers and improve cancer screening rates

Early diagnosis of cancer is linked to better survival rates. Unfortunately, participation rates for cancer screening worldwide are low even when screening programmes are free.

6 Oct 2016

Leading scientists convene to discuss applications of bioelectronic medicine

In a first-of-its-kind gathering at the New York Academy of Sciences, researchers from some of the world's leading universities and institutions convened to discuss the various applications of bioelectronic medicine, the cutting-edge field that uses technology to treat disease and injury.

6 Oct 2016

Revised prostate cancer guidelines did not reduce usage of PSA tests, study finds

Controversy over prostate cancer screening guidelines that discourage use of PSA tests did not significantly reduce use of the test, a five-year review of more than 275,000 visits at UT Southwestern Medical Center showed.

6 Oct 2016

UV disinfection device effectively reduces risk of C. difficile infections

Ultraviolet C light disinfection to clean unoccupied patient rooms significantly reduced C. difficile infections (CDI) in high-risk patients who later occupied those rooms, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

6 Oct 2016

Researchers awarded grant to develop safer cancer therapies for children

Two Case Western Reserve University School of Medicine researchers are receiving new funding from California-based St. Baldrick's Foundation for promising childhood cancer research.

5 Oct 2016

Oncology News and Research

Further Reading

Sense Media launch MediSens: a highly-anticipated European medical imaging conference

Study highlights burden, poor prognosis of head and neck cancers linked to tobacco/alcohol

Survey finds seven out of ten cancer patients receive palliative care consultation at ESMO Designated Centres

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Study of pan-FGFR inhibitor uses mRNA in tumours to identify responders

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

First comprehensive center opened in Tri-State area to mark new era in care of DMD patients

Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

Study finds neoadjuvant immunotherapy safe, viable for early lung cancer patients before surgery

Pitt researchers show how repair protein finds structural errors in DNA

Studies look at alternative ways to overcome barriers and improve cancer screening rates

Leading scientists convene to discuss applications of bioelectronic medicine

Revised prostate cancer guidelines did not reduce usage of PSA tests, study finds

UV disinfection device effectively reduces risk of C. difficile infections

Researchers awarded grant to develop safer cancer therapies for children

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News